The hit the co took last year when they lost the Tissue customer is now finally absorbed.
When you compare this qtr to the last, you'll see a slight improvement over most everything.
As has been the case now quite a long time, no change in the share structure, and no toxic notes.
CASH increased by $226,471 over last qtr...
Nothing earthshattering, but this co is on firm ground right now.
Sandberg didn't make a statement, that kind of disappoints me...although we all know statements don't mean anything without action.
Sitting on almost a million in cash, with the current qtr half over I would guess it's over a ml now.
Lets do something creative with the cash, it's now time.
